Performance at Month End

Merrill Lynch UK Inv Tst PLC 16 October 2002 MONTHLY PERFORMANCE MERRILL LYNCH UK INVESTMENT TRUST plc All information is at 30 September 2002 and unaudited. Performance at month end with net income reinvested One Three One Three Five month months year years years Net asset value -12.3% -21.8% -26.1% -45.6% -35.7% Share price -19.2% -30.5% -34.5% -55.5% -50.1% FTSE All-Share Index -11.8% -19.6% -20.8% -31.2% -16.8% Sources: Merrill Lynch Investment Managers, Standard & Poor's Micropal At month end Net asset value* 602.99p Share price: 455.00p Discount: 24.5% Total assets: £118.6m Net Yield: 6.3% Gearing: 49.9% Effective gearing: 14.6% Value of debt: £39.5m Ordinary shares in issue: 13,368,799 *Includes current year net revenue of 11.40p. UK Sectors % Total Assets Financials 22.1 Cyclical Services 14.8 Non-Cyclical Consumer Goods 14.1 Resources 11.1 Non-Cyclical Services 7.2 Basic Industries 2.1 Utilities 2.0 General Industrials 1.7 Information Technology 1.2 Cash 25.5 Net current liabilities (1.8) Total 100.0 Ten Largest Equity Investments Company % Investments BP 8.8 GlaxoSmithKline 5.8 HSBC 5.8 HBOS 5.7 Barclays 5.2 Royal Bank of Scotland 4.4 Vodafone 4.1 AstraZeneca 3.8 Next 3.7 Amersham 3.6 Total 50.9 Market commentary UK Stockmarket Review The UK equity market was weak in September, with the FTSE All-Share falling 11.8%. Falls were particularly savage towards the end of the month, and the FTSE 100 experienced its worst quarterly performance since the last three months of 1987. September saw a continuation of August trends, with nervousness surrounding economic growth prospects and shaky investor and consumer confidence. These concerns were compounded by the prospect of a war in Iraq. Performance Review The Company's Net Asset Value (NAV) fell 12.3% in September, slightly behind the FTSE All Share Index. Defensive shares continued to outperform as falling stockmarkets caused investors to seek the relative safety of companies with reliable and visible earnings. Holdings in the healthcare sector, notably Amersham and Smith & Nephew were helpful, although the lack of exposure to other defensive areas such as food producers and electricity detracted from performance. Banks remained under pressure and although we benefited from not holding Abbey National, this was offset by the holdings in HBOS and Barclays, which also underperformed. Life assurance companies continued to underperform, making the sector one of the worst performers over the third quarter. Our low exposure here was positive. Construction shares suffered on concerns over the future shape of Public Finance Initiatives (PFI), and the Trust suffered from the holding in McAlpine. The overweight position in clothing retailer Next was particularly positive over the month, as the shares continue to perform well. We benefited from our lack of exposure to BAe Systems, which fell sharply after announcing a loss in the first half of the year due to programme delays. Outlook Ongoing economic uncertainty and the potential for further corporate scandals (both phenomena generally outside of the UK itself) are likely to perpetuate the volatility and nervousness of the UK stockmarket. Over the longer term, there are a number of trends within the UK that we expect to enhance earnings growth for the companies involved. These include outsourcing, pricing power, volume growth and corporate restructuring. Latest information is available by typing www.mlim.co.uk/its on the internet, 'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal). 15 October 2002 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings